Correlation Between AnaptysBio and Stoke Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AnaptysBio and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AnaptysBio and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AnaptysBio and Stoke Therapeutics, you can compare the effects of market volatilities on AnaptysBio and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AnaptysBio with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AnaptysBio and Stoke Therapeutics.

Diversification Opportunities for AnaptysBio and Stoke Therapeutics

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between AnaptysBio and Stoke is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and AnaptysBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AnaptysBio are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of AnaptysBio i.e., AnaptysBio and Stoke Therapeutics go up and down completely randomly.

Pair Corralation between AnaptysBio and Stoke Therapeutics

Given the investment horizon of 90 days AnaptysBio is expected to under-perform the Stoke Therapeutics. In addition to that, AnaptysBio is 1.8 times more volatile than Stoke Therapeutics. It trades about -0.17 of its total potential returns per unit of risk. Stoke Therapeutics is currently generating about -0.06 per unit of volatility. If you would invest  1,472  in Stoke Therapeutics on September 14, 2024 and sell it today you would lose (240.00) from holding Stoke Therapeutics or give up 16.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

AnaptysBio  vs.  Stoke Therapeutics

 Performance 
       Timeline  
AnaptysBio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AnaptysBio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Stoke Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

AnaptysBio and Stoke Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AnaptysBio and Stoke Therapeutics

The main advantage of trading using opposite AnaptysBio and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AnaptysBio position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.
The idea behind AnaptysBio and Stoke Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity